|
市場調查報告書
細胞毒殺性治療市場的預測
Cytotoxic Therapies Market Forecast
|
細胞毒殺性治療市場的預測 是由出版商Datamonitor在2010年08月所出版的。
這份英文市場調查報告書價格從美金15200起跳。
細胞毒殺性治療市場的CAGR為-0.1%，由於降血脂藥物的專利失效導致銷售減少，市場整體呈現負成長。
針對2009年至2019年全球七大市場在細胞毒殺性治療的發展動態，本服務彙整相關的調查分析，包括主要品牌的動態與阻礙市場成長的因素，以及學名藥的評價基準等介紹，內容概要摘記如下。
- 導論
- 調查範圍
- 調查/分析重點
- 利用本服務的主要理由
- 預測方法
Abstract
Introduction
Growth of cytotoxics will remain static over the forecast period with a CAGR
of -0.1%. Several blockbuster products are due to undergo patent expiry over
the forecast period and the loss of their branded sales will negatively impact
on the growth of this market. But the launch of a number of drugs in rare
indications will stabilize growth in this market and offset its decline from
generic entry.
Reasons to Purchase
- Quantify the performance of each of the marketed cytotoxic therapy cancer
brands in the seven major markets over the period 2009 to 2019
- Acquire a detailed account of cytotoxic therapy cancer brand dynamics and
the events that drive and limit their market growth
- Benchmark the cytotoxic therapy cancer brands against their generics and
rest of class and align their 7MM performance with a rest of world snapshot
Table of Contents
OVERVIEW
- This product contains forecasts for the cytotoxic cancer therapies across
the seven major markets from 2009 to 2019. It has been designed for delivery
in an excel data pack format.
- The associated report and PowerPoint presentation can be found under
Latest research in the Knowledge centre, through the search function or by
contacting your sales representative.
- Introduction
- Research and analysis highlights
- Key reasons to read this report
- Forecasting Methodology
- The forecasting model
- General event information
- Event selection and quantification
- Event parameters
|
